BPC-157 & TB-500

Tendon & Ligament Repair Gut Healing Systemic Recovery Angiogenesis Anti-Inflammatory

About This Compound

BPC-157 & TB-500 is a precision-formulated dual-peptide blend that combines two of the most extensively studied repair compounds in preclinical research. By pairing a locally-acting repair peptide with a systemically-distributed one, the stack addresses both site-specific injury and the broader inflammatory and regenerative environment.

BPC-157 (Body Protection Compound-157) is a synthetic 15-amino acid peptide isolated from human gastric juice. In research models it has demonstrated accelerated healing of tendon, ligament, muscle, and gastrointestinal tissue — upregulating growth factor receptors (VEGFR2, FGFR) and activating the FAK-paxillin signalling pathway to drive rapid cellular repair and angiogenesis at the injury site.

TB-500 (Thymosin Beta-4 Analogue) is a 43-amino acid synthetic peptide that binds G-actin via its conserved LKKTET motif. This interaction promotes cell migration, endothelial tube formation, and vascular regeneration body-wide — making TB-500 uniquely suited for systemic distribution throughout connective and vascular tissue rather than acting only at a localised site.

Together, BPC-157 addresses the injury focus point while TB-500 resolves inflammation and rebuilds supporting vasculature system-wide — a complementary mechanism that neither peptide achieves in isolation.

Technical Specifications

Half-Life 4–6 h (BPC-157) / 6–7 days (TB-500)

Research Dose Range BPC-157: 250–500 mcg/day · TB-500: 2.5–5 mg/week

Physical Form Lyophilised dual-peptide vial

Storage Conditions Refrigerate (2–8 °C) after reconstitution. Use within 28 days.

Amino Acid Composition BPC-157: 15 AA · TB-500: 43 AA

CAS Number BPC-157: 137525-51-0 · TB-500: 77591-33-4

Purity (HPLC) ≥ 99.5% (HPLC verified — full COA available)

🔬 Research & Mechanism Notes

Mechanism

BPC-157 activates VEGFR2, EGF-R, and FAK-paxillin — driving tendon and GI repair. TB-500 binds G-actin via LKKTET motif, promoting stem cell mobilisation and vessel formation.

Preclinical Evidence

Demonstrated accelerated tendon-to-bone healing, reduction of GI lesions, and systemic anti-inflammatory effects in multiple rodent models (rats, mice).

Synergy

BPC-157 operates locally at the injury site; TB-500 distributes systemically. The combination provides complementary, full-spectrum tissue repair coverage.

Storage Note

Lyophilised form is stable at −20 °C for up to 24 months. After reconstitution with bacteriostatic water, refrigerate and use within 28 days.

Bulk Deals

Buy more vials, pay for fewer. Deals apply automatically per compound in your cart — the more you stock up, the less you pay per vial.

Pack	You Pay	Per Vial	You Save
1 vial	€89.94	€89.94	—
5 vials (pay for 4)	€359.76	€71.95	20% off
10 vials (pay for 7)	€629.58	€62.96	30% off
Monthly subscription (per vial)	€76.45/mo	€76.45	15% off

≥ 99.5%

€89.94

Per vial · bulk deals up to 30% off

VAT (21%) included

Select Variant

10mg / vial BPC-TB-10

€89.94

20mg / vial BPC-TB-20

€149.94

30mg / vial BPC-TB-30

€209.94

One-time

Buy 1 · 5 · 10

Monthly · 15% off

Choose Your Pack

Single vial

1 vial

—

5-Pack PAY FOR 4

5 vials · save 20%

—

10-Pack PAY FOR 7

10 vials · save 30%

—

Quantity

View Certificate of Analysis (COA)

Freeze-dried · ISO Class 5 vacuum filled

Robotically hermetic-sealed

100% UV-A contamination inspected

Fast, discreet EU delivery

For research use only. Not intended for human or veterinary therapeutic use. Not evaluated by the FDA or EMA.